Visualitzant VHIO - Articles científics per títol
Ara mostrant els elements 554-573 d 880
-
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
(Frontiers Media, 2023-02-24) -
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
(American Society of Clinical Oncology, 2022-09-01) -
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial
(American Society of Clinical Oncology, 2023-01-20) -
p27Kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor–positive breast cancer
(Oxford University Press, 2023-04) -
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication
(SAGE Publications, 2019-05-10) -
Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial
(American Association for Cancer Research, 2023-01-04) -
Pan-cancer Analysis of Homologous Recombination Repair–associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score
(American Association for Cancer Research, 2022-04-01) -
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
(Nature Research, 2022-08) -
Pan-cancer whole-genome comparison of primary and metastatic solid tumours
(Nature Portfolio, 2023-06) -
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma
(American Society of Clinical Oncology, 2020-10-20)